ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

PSMA-targeted arsenic nanosheets: a platform for prostate cancer therapy via ferroptosis and ATM deficiency-triggered chemosensitization

Wang, Hui; Zhang, Li; Miao, Zhaohua; Zhang, Meng; Liu, Hang; He, Qiong; Meng, Jialin; Wen, Longping; Ke, Zunfu; Zha, Zhengbao*; Lin, Run*; Liang, Chaozhao*安徽医科大学; 中山大学; 1
Materials Horizons2021-8-1DOI: 10.1039/d0mh01992e
12被引11阅读
引用收藏
分享

摘要

Ferroptosis, a newly recognized form of non-apoptotic cell death, has recently been introduced for effective cancer therapy. The reported ferroptosis-inducing nanomaterials mainly consisted of metal-based components. Herein, we designed an inorganic metal-free nanoplatform, PSMA-targeted arsenic nanosheets (PMANs), which simultaneously increased glutathione (GSH) consumption, suppressed solute carrier family 7 member 11 (SLC7A11) and glutathione-dependent peroxidase 4 (GPX4) expression, and promoted the generation of reactive oxygen species (ROS) and lipid peroxides (LPO). In addition, owing to the large surface area, PMANs efficiently transported doxorubicin (DOX) to prostate cancer for synergistic therapy. Surprisingly, we found that PMANs could sensitize prostate cancer cells to DOX through downregulating the expression of ataxia telangiectasia mutated (ATM), which further augmented the GPX4 downregulation-mediated ferroptotic tumoricidal effect. Given that arsenic trioxide has been routinely and successfully used in the clinical treatment of leukemia for a long time, we anticipate that PMANs will offer a promising strategy for prostate cancer therapy.

学科与关键词

关键词
CHEMOTHERAPYMECHANISMSRESISTANCEDEATH
相关
加载中…
  • Anti-Her2 affibody-decorated arsenene nanosheets induce ferroptosis through depleting intracellular GSH to overcome cisplatin resistance
    He, Peng; Xu, Shenglin; Miao, Zhaohua; Que, Yukang; Chen, Yu; Li, Sheng; Ma, Qiming; Yang, Rui; Wei, Wei*; Zha, Zhengbao*; Hu, Yong*JOURNAL OF NANOBIOTECHNOLOGY, 2023, 21(1): 203.被引 4
  • Liposome-coated nanoparticle triggers prostate cancer ferroptosis through synergetic chemodynamic-gas therapy
    Hong, Yingkai; Hou, Wenli; Ou, Dehua; Lin, Mingen; Luo, Mayao; Wei, Qiang*Nanoscale Advances, 2024, 6(2): 524-533.
  • Ferroptosis-Based Therapeutic Strategies toward Precision Medicine for Cancer
    Shi, Tong-Mei; Chen, Xiao-Fei*; Ti, Huihui*Journal of Medicinal Chemistry, 2024, 67(4): 2238-2263.
查看全部 →

发表信息

论文状态
公开发表
期刊
Materials Horizons
发表日期
2021-08-01
卷期
第 8 卷, 第 8 期
页码
2216-2229
DOI
10.1039/d0mh01992e
语言
ENGLISH
期刊收录
NSL
期刊等级
1区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [31800834, 81773299, 82072055, 82072040]; Key Project of Provincial Natural Science Research Project of Anhui Colleges [KJ2019A0278]; Supporting Project for Distinguished Young Scholar of Anhui Colleges [gxyqZD2019018]; Anhui Provincial Institutes for Translational Medicine [2017ZHYX02]; University Synergy Innovation Program of Anhui Province [GXXT-2019-045]

作者

  • W

    Wang, Hui (第一作者)

    anhui med univ · 1

  • Z

    Zhang, Li

    anhui med univ · 1

查看全部 12 位作者收起作者
  • M

    Miao, Zhaohua

  • Z

    Zhang, Meng

    anhui med univ · 1

  • L

    Liu, Hang

  • H

    He, Qiong

    1 · sun yat sen univ

  • M

    Meng, Jialin

    anhui med univ · 1

  • W

    Wen, Longping

    anhui med univ · 1

  • K

    Ke, Zunfu

    1 · sun yat sen univ

  • Z

    Zha, Zhengbao (通讯)

  • L

    Lin, Run (通讯)

    1 · sun yat sen univ

  • L

    Liang, Chaozhao (通讯)

    anhui med univ · 1

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417